First Eagle Investment Management, LLC Assertio Holdings, Inc. Transaction History

First Eagle Investment Management, LLC

  • $48.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023
BUY
$5.0 - $7.66 $888,250 - $1.36 Million
177,650 Added 20.66%
1,037,604 $5.62 Million
Q1 2023

May 11, 2023
BUY
$3.54 - $6.66 $608,451 - $1.14 Million
171,879 Added 24.98%
859,954 $5.48 Million
Q4 2022

Feb 09, 2023
BUY
$2.11 - $4.3 $396,840 - $808,726
188,076 Added 37.62%
688,075 $2.96 Million
Q3 2022

Nov 10, 2022
BUY
$2.13 - $4.0 $532,384 - $999,784
249,946 Added 99.96%
499,999 $1.14 Million
Q2 2022

Aug 10, 2022
BUY
$1.88 - $3.42 $470,099 - $855,181
250,053 New
250,053 $738,000

Others Institutions Holding ASRT

# of Institutions
97
Shares Held
31M
Call Options Held
957K
Put Options Held
38.5K
View Full List

About Assertio Holdings, Inc.

ASRT Quotes by TradingView
  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $41.9M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track First Eagle Investment Management, LLC Portfolio

Follow First Eagle Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Eagle Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email